USOR - Virginia Cancer Specialists - Fairfax Office

Fairfax, Virginia 22031

1 studies enrolling now · 4 studies all time

What they study most

ALK-positive Advanced NSCLC, Advanced Non-Small Cell Lung Cancer, Advanced or Metastatic RAS Mutant Colorectal and Pancreatic Ductal Cancers, Colorectal Cancer, Metastatic Non-Small Cell Lung Cancer, Pancreatic Ductal Cancer, Solid Tumors

Studies at this site

• Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7 — Recruiting now
• A Study of DF6002 Alone and in Combination With Nivolumab — Completed
• A Study of Brigatinib in Participants With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib — Completed
• A Study to Investigate BGB-3245 (Brimarafenib) With Panitumumab in Participants With Advanced or Metastatic RAS Mutant Colorectal and Pancreatic Ductal Cancers — Stopped early